1-4 of 4
Hong-Nam Nguyen
Close
Sort by
Journal Articles

JAK1 and JAK2 Modulate Myeloma Cell Susceptibility to NK Cells Through the Interferon Gamma (IFN-γ) Pathway,

Roberto Bellucci, PhD, Allison Martin, BS, Marc Buren, Hong-Nam Nguyen, BS, Davide Bommarito, Jerome Ritz, MD
Journal: Blood
Blood (2011) 118 (21): 3960.
https://doi.org/10.1182/blood.V118.21.3960.3960
Published: 2011
Journal Articles

NOVEL Pathways Modulate TUMOR CELL Susceptibility to NK CELLS.

Roberto Bellucci, Ph.D, Hong-Nam Nguyen, Allison Martin, Anna C. Schinzel, PhD, Stefan Heinrichs, PhD, William C. Hahn, MD, PhD, Jerome Ritz, MD
Journal: Blood
Blood (2009) 114 (22): 277.
https://doi.org/10.1182/blood.V114.22.277.277
Published: 2009
Journal Articles

Genetic Screening for Myeloma Cell Susceptibility to NK Cell Mediated Lysis Using Large Lentiviral shRNA Libraries

Roberto Bellucci, Ph.D, Hong-Nam Nguyen, Allison Martin, Anna Schinzel, Ph.D, John Daley, Steen Hansen, M.D., Ph.D, William C. Hahn, M.D., Ph.D, Jerome Ritz, M.D.
Journal: Blood
Blood (2008) 112 (11): 2900.
https://doi.org/10.1182/blood.V112.11.2900.2900
Published: 2008
Journal Articles

PDC-E2, a Common Auto Antigen in Primary Biliary Cirrhosis (PBC) Is Also a Target of an Antibody Response in Patients Who Achieve Complete Remission after Donor Lymphocyte Infusion.

Roberto Bellucci, Ph.D, Meagan Gallagher, B.S., Hong-Nam Nguyen, Edwin P. Alyea, MD, Emmanuel Zorn, Ph.D, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD, Jerome Ritz, MD
Journal: Blood
Blood (2004) 104 (11): 2121.
https://doi.org/10.1182/blood.V104.11.2121.2121
Published: 2004